Tnk1/Kos1 knockout mice develop spontaneous tumors

Cancer Research

Volumn 68, Issue 21, 2008, Pages 8723-8732

  Hoare, Sarasija ^a   Hoare, Kishalay ^a   Reinhard, Mary K ^b   Lee, Young J ^a,c   Oh, S Paul ^a,c   May Jr , W Stratford ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b University of Florida College of Veterinary Medicine   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; GENE PRODUCT; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; GUANINE NUCLEOTIDE EXCHANGE FACTOR; KOS1 PROTEIN; PROTEIN TYROSINE KINASE; RAS PROTEIN; SOS PROTEIN; TNK1 PROTEIN; UNCLASSIFIED DRUG;

ANGIOSARCOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL CELL; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CARCINOMA; CONTROLLED STUDY; DISEASE COURSE; EMBRYO CELL; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; EPIGENETICS; FEMALE; FIBROBLAST; GENE ACTIVATION; GENE DISRUPTION; GENE EXPRESSION; GENE REPRESSION; GENE SILENCING; GENE TARGETING; HISTIOCYTIC LYMPHOMA; HISTOPATHOLOGY; HOMOLOGOUS RECOMBINATION; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; LIPOMA; LIVER CELL CARCINOMA; LUNG ADENOCARCINOMA; LYMPHOMA; MALE; METHYLATION; MOUSE; NONHUMAN; NULL ALLELE; PANCREAS CANCER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; RNA SPLICING; TISSUE; TRICHOEPITHELIOMA; TUMOR SUPPRESSOR GENE;

ALLELES; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELLS, CULTURED; DNA PRIMERS; EPIGENESIS, GENETIC; GENE SILENCING; GENE TARGETING; IMMUNOPRECIPITATION; MICE; MICE, KNOCKOUT; NEOPLASMS, EXPERIMENTAL; PROTEIN-TYROSINE KINASES;

EID: 55349108502     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-1467     Document Type: Article

References (40)

1. Hoehn GT, Stokland T, Amin S, et al. Tnk1: a novel intracellular tyrosine kinase gene isolated from human umbilical cord blood CD34+/Lin-/CD38- stem/progenitor cells. Oncogene 1996;12:903-13.
2. Azoitei N, Brey A, Busch T, Fulda S, Adler G, Seufferlein T. Thirty-eight-negative kinase1 (TNK1) facilitates TNFα-induced apoptosis by blocking NF-κB activation. Oncogene 2007;26:6536-45.
3. Hoare K, Hoare S, Smith OM, Kalmaz G, Small D, May WS. Kos1, a nonreceptor tyrosine kinase that suppresses Ras signaling. Oncogene 2003;22:3562-77.
4. Manser E, Leung T, Salihuddin H, Tan L, Lim L. A nonreceptor tyrosine kinase that inhibits the GTPase activity of p21cdc42. Nature 1993;363:364-67.
5. Yang W, Cerione RA. Cloning and characterization of a novel Cdc42-associated tyrosine kinase, ACK-2, from bovine brain. J Biol Chem 1997;272:24819-24.
6. Kolch W. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem J 2000;351:289-5.
7. Kolch W. Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat Rev Mol Cell Biol 2005;6:827-37.
8. Lowenstein EJ. The SH2 and SH3 domain containing protein Grb2 links receptor tyrosine kinases to Ras signaling. Cell 1992;70:431-42.
9. Vetter IR, Wittinghofer A. The guanine nucleotide-binding switch in three dimensions. Science 2001;294:1299-4.
10. Malumbres M, Barbacid M. Ras oncogenes: the first 30 years. Nat Rev 2002;3:7-13.
11. Xu G F, O'Connell P, Viskochil D, et al. The Neurofibromatosis type1 gene encodes a protein related to GAP. Cell 1990;62:599-8.
12. McCormick F. Ras GTPase activating protein: signal transmitter and signal terminator. Cell 1989;56:5-8.
13. Chardin P, Camonis JH, Gale NW, et al. Human Sos1: a guanine nucleotide exchange factor for Ras that binds to Grb2. Science 1993;260:1338-43.
14. Buday L, Downward J. Epidermal growth factor regulates the exchange rate of guanine nucleotides on p21ras in fibroblasts. Mol Cell Biol 1993;13:1903-10.
15. Downward, J. Targeting Ras signaling pathways in cancer therapy. Nat Rev Cancer 2003;3:11-22.
16. Manne V, Bekesi E, King H-F. Ha-Ras proteins exhibit GTPase activity: point mutations that activate Ha-Ras gene product results in decreased GTPase activity. Proc Natl Acad Sci U S A 1985;82:376-80.
17. Bos JL. Ras oncogene in human cancer. Cancer Res 1989;49:4682-9.
18. Scheffzek K, Ahmadian MR, Kobsch N, et al. The Ras-Ras GAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants. Science 1997;277:333-8.
19. Lao DH, Chandramouli S, Yusoff P, et al. A Src homology 3-binding sequence on the C terminus of Sprouty2 is necessary for inhibition of the Ras/ERK pathway downstream of fibroblast growth factor receptor stimulation. J Biol Chem 2006;281:29993-0.
20. Gross I, Basset B, Benezra M, Licht JD. Mammalian Sprouty proteins inhibit cell growth and differentiation by preventing Ras activation. J Biol Chem 2001;276:46460-8.
21. Perrimon N, McMahon AP. Negative feedback mechanism and their roles in pattern formation. Cell 1999;97:13-6.
22. The I, Murthy AE, Hannigan GE, et al. Neurofibromatosis gene mutations in neuroblastoma. Nat Genet 1993;3:62-6.
23. ras contributes to malignant tumor growth in von Recklinghausen (type1) neurofibromatosis. Cell 1992;69:265-73.
24. Bollag G, Clapp DW, Shih S, et al. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. Nat Genet 1996;12:144-8.
25. Jacks T, Shih TS, Schmitt EM, Bronson RT, Bernards A, Weinberg RA. Tumor predisposition in mice heterozygous for a targeted mutation in NF1. Nat Genet 1994;7:353-61.
26. Tommasi S, Dammann R, Zhang Z, et al. Tumor susceptibility of Rassf1a knockout mice. Cancer Res 2005;65:92-8.
27. Donninger H, Vos MD, Clark GJ. The RASSF1A tumor suppressor. J Cell Sci 2007;120:3163-72.
28. Li B-Q, Kaplan D, Kung H, Kamata T. Nerve growth factor stimulation of the Ras-Guanine Nucleotide Exchange Factor and GAP Activities. Science 1992;256:1456-9.
29. Li S, Couvillon AD, Brasher BB, Van Etten RA. Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling. EMBO J 2001;20:6793-4.
30. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 1998;72:141-96.
31. Bird AP, Wolffe AP. Methylation induced repression: belts, braces and chromatin. Cell 1999;99:451-54.
32. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002;3:415-28.
33. Felscow DM, Civin CI, Hoehn GT. Characterization of the tyrosine kinase Tnk1 and its binding with phospholipase C-γ1. BBRC 2000;273:294-1.
34. Davies H, Hunter C, Smith R, et al. Somatic mutations of the protein kinase gene family in human lung cancer. Cancer Res 2005;65:7591-5.
35. Maignan S, Guilloteau JP, Fromage N, et al. Crystal structure of the mammalian Grb2 adaptor. Science 1995;268:291-3.
36. Kardinal C, Konkol B, Lin H, et al. Chronic myelogenous leukemia blast cell proliferation is inhibited by peptides that disrupt Grb2-1 complexes. Blood 2001;98:1773-81.
37. Feller SM, Tuchscherer G, Voss J. High affinity molecules disrupting GRB2 protein complexes as a therapeutic strategy for chronic myelogenous leukaemia. Leuk Lymphoma 2003;44:411-27.
38. Gishizky ML, Cortez D, Pendergast AM. Mutant forms of growth factor-binding protein-2 reverse BCR-ABL-induced transformation. Proc Natl Acad Sci U S A 1995;92:10889-93.
39. Santarosa M, Ashworth A. A. Haploinsufficiency for tumor suppressor genes: when you don't need to go all the way. Biochim Biophys Acta 2004;1654:105-22.
40. Cook WD, McCaw B J. Accomodating haplosufficient tumor suppressor gene in Knudson's model. Oncogene 2000;19:3434-8.